OTCPK:MEDVF - Post by User
Comment by
Sarb99on Aug 27, 2020 11:51am
778 Views
Post# 31460619
RE:RE:Quest Cap Takes Control of Las Vegas TESTING!
RE:RE:Quest Cap Takes Control of Las Vegas TESTING!You are Right and also Wrong Lol.
When you visit your health care provider or a Lab cost will be very similar to Antibbody test. Also all these Chinese Antibody test kits, wholesale cost probably be $5-$10
Your product is a lateral flow immunoassay intended for the qualitative detection of nucleocapsid protein antigen from SARS-CoV-2 in direct nasal swabs from individuals suspected of COVID-19 by their healthcare provider within the first seven days of symptom onset. The SARS-CoV-2 nucleocapsid protein antigen is generally detectable in nasal swabs during the acute phase of infection. Positive results indicate the presence of viral antigens, but clinical correlation with patient history and other diagnostic information is necessary to determine infection status. Positive results do not rule out bacterial infection or co-infection with other viruses. Negative results do not rule out SARS-CoV-2 infection and should not be used as the sole basis for treatment or patient management decisions, including infection control decisions. Negative results should be considered in the context of a patient’s recent exposures, history and presence of clinical signs and symptoms consistent with COVID-19.
Testing of nasal swab specimens using your product, as outlined in the “BinaxNOW COVID-19 Ag CARD,” Instructions for Use, is limited to laboratories certified under CLIA that meet the requirements to perform high, moderate, or waived complexity tests. This test is authorized for use at the POC, i.e., in patient care settings operating under a CLIA Certificate of Waiver, Certificate of Compliance, or Certificate of Accreditation.